Press Release - | Dystrophin Market to Reach USD USD 30.22 Billion Billion by 2028 |
Vantage Market Research | 30 Jan 2022
Biotechnology and Life Sciences
Dystrophin Market to Reach USD USD 30.22 Billion Billion by 2028
The Dystrophin Market is expected to reach USD USD 30.22 Billion billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 45.9% in between 2022 to 2028. A deficiency or absence of Dystrophin is accountable for two disorders that cause progressive muscle destruction. The absence of this drug impairs the honour of the sarcolemma membrane, assimilating the membrane exposed to mechanical damage.
Key Findings:
Some of key players in Dystrophin Market is - PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, Bristol-Myers Squibb and Catabasis, Pharmaceuticals among others..
The market is defined by the entry of a big number of market players that include developing companies, as well as pharma giants. The key factor, for the focus of these players, is the untapped demand for muscular dystrophy diseases treatment for a long time. There are more than 35 companies committed in clinical trials for the novel therapeutics launch for the treatment of DMD. Owing to strict regulation for drug approval across the globe, very few drug applicants received approval from regulatory bodies in medicine such as the U.S. FDA and European Commission.
Asia Pacific market is likely to reflect substantial growth in the coming years due to expecting drug launches in the region. A suitable scenario for funds for research and development and the presence of numerous emerging market players in the region is anticipated to promote the growth of the market over the forecast period.
Biotechnology and Life Sciences
Dystrophin Market to Reach USD USD 30.22 Billion Billion by 2028
30 Jan 2022
Min Read
Access Full Report
Dystrophin Market to Reach USD USD 30.22 Billion Billion by 2028
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleContact
Toll Free Number+1 (877) 462-2282